These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28639412)

  • 41. CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis.
    Lescoat A; Lecureur V; Roussel M; Sunnaram BL; Ballerie A; Coiffier G; Jouneau S; Fardel O; Fest T; Jégo P
    Clin Rheumatol; 2017 Jul; 36(7):1649-1654. PubMed ID: 28293753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reassessing the Role of the Active TGF-
    Dantas AT; Gonçalves SM; de Almeida AR; Gonçalves RS; Sampaio MC; Vilar KM; Pereira MC; Rêgo MJ; Pitta ID; Marques CD; Duarte AL; Pitta MG
    Dis Markers; 2016; 2016():6064830. PubMed ID: 27965520
    [No Abstract]   [Full Text] [Related]  

  • 43. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
    Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
    Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis.
    Maugeri N; Rovere-Querini P; Baldini M; Baldissera E; Sabbadini MG; Bianchi ME; Manfredi AA
    Antioxid Redox Signal; 2014 Mar; 20(7):1060-74. PubMed ID: 24070090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis.
    Takahashi T; Asano Y; Noda S; Aozasa N; Akamata K; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Br J Dermatol; 2015 Sep; 173(3):681-9. PubMed ID: 25781362
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis.
    Svegliati S; Marrone G; Pezone A; Spadoni T; Grieco A; Moroncini G; Grieco D; Vinciguerra M; Agnese S; Jüngel A; Distler O; Musti AM; Gabrielli A; Avvedimento EV
    Sci Signal; 2014 Sep; 7(341):ra84. PubMed ID: 25185156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis.
    Bergmann C; Brandt A; Merlevede B; Hallenberger L; Dees C; Wohlfahrt T; Pötter S; Zhang Y; Chen CW; Mallano T; Liang R; Kagwiria R; Kreuter A; Pantelaki I; Bozec A; Abraham D; Rieker R; Ramming A; Distler O; Schett G; Distler JHW
    Ann Rheum Dis; 2018 Jan; 77(1):150-158. PubMed ID: 29070530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis.
    Mokuda S; Miyazaki T; Ubara Y; Kanno M; Sugiyama E; Takasugi K; Masumoto J
    Arthritis Res Ther; 2015 Sep; 17():275. PubMed ID: 26419626
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low heme oxygenase-1 levels in patients with systemic sclerosis are associated with an altered Toll-like receptor response: another role for CXCL4?
    van Bon L; Cossu M; Scharstuhl A; Pennings BW; Vonk MC; Vreman HJ; Lafyatis RL; van den Berg W; Wagener FA; Radstake TR
    Rheumatology (Oxford); 2016 Nov; 55(11):2066-2073. PubMed ID: 27411481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.
    Zhu H; Luo H; Zuo X
    Exp Mol Med; 2013 Sep; 45(9):e41. PubMed ID: 24052166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The elevated expression of Th17-related cytokines and receptors is associated with skin lesion severity in early systemic sclerosis.
    Zhou Y; Hou W; Xu K; Han D; Jiang C; Mou K; Li Y; Meng L; Lu S
    Hum Immunol; 2015 Jan; 76(1):22-9. PubMed ID: 25500255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis.
    Bohgaki T; Amasaki Y; Nishimura N; Bohgaki M; Yamashita Y; Nishio M; Sawada KI; Jodo S; Atsumi T; Koike T
    Ann Rheum Dis; 2005 Aug; 64(8):1165-73. PubMed ID: 16014681
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target.
    Henderson J; Distler J; O'Reilly S
    Trends Mol Med; 2019 May; 25(5):395-411. PubMed ID: 30858032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The magnitude of cytokine production by stimulated CD56
    Cossu M; van Bon L; Nierkens S; Bellocchi C; Santaniello A; Dolstra H; Beretta L; Radstake TR
    Clin Immunol; 2016 Dec; 173():76-80. PubMed ID: 27616458
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis.
    Huang J; Maier C; Zhang Y; Soare A; Dees C; Beyer C; Harre U; Chen CW; Distler O; Schett G; Wollin L; Distler JHW
    Ann Rheum Dis; 2017 Nov; 76(11):1941-1948. PubMed ID: 28814429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis.
    Andersen GN; Nilsson K; Pourazar J; Hackett TL; Kazzam E; Blomberg A; Waldenström A; Warner J; Rantapää-Dahlqvist S; Mincheva-Nilsson L; Sandström T
    Respir Med; 2007 Oct; 101(10):2199-206. PubMed ID: 17643278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis.
    Svegliati S; Spadoni T; Moroncini G; Gabrielli A
    Free Radic Biol Med; 2018 Sep; 125():90-97. PubMed ID: 29694853
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.